Tetragenetics, based in Lansing, NY, is a pioneering company breaking barriers in the development of advanced antibody medicines for patients. With a focus on innovation and collaboration, they partner with leading pharmaceutical companies and utilize cutting-edge technologies to unlock high-value drug classes and targets, including T-cell engagers for cancer and transmembrane proteins for various medical conditions.
Comprised of a diverse team of dedicated professionals, Tetragenetics is committed to advancing science and technology to bring better therapies to patients. Their collaborative environment fosters a sense of purpose and empowers individuals to contribute their unique skills towards tackling significant global health challenges.
Generated from the website